As of close of business last night, Kintara Therapeutics Inc’s stock clocked out at $0.09, down -4.80% from its previous closing price of $0.10. In other words, the price has decreased by -$0.0046 from its previous closing price. On the day, 3909317 shares were traded. KTRA stock price reached its highest trading level at $0.0941 during the session, while it also had its lowest trading level at $0.0862.
Ratios:
To gain a deeper understanding of KTRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.63.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KTRA now has a Market Capitalization of 3.53M and an Enterprise Value of 13.12M.
Stock Price History:
Over the past 52 weeks, KTRA has reached a high of $5.98, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is 0.1426, while the 200-Day Moving Average is calculated to be 2.4199.
Shares Statistics:
It appears that KTRA traded 9.15M shares on average per day over the past three months and 17.02M shares per day over the past ten days. A total of 39.04M shares are outstanding, with a floating share count of 38.16M. Insiders hold about 2.25% of the company’s shares, while institutions hold 0.62% stake in the company. Shares short for KTRA as of Jan 31, 2024 were 164.04k with a Short Ratio of 0.02, compared to 121.57k on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.84% and a Short% of Float of 4.85%.
Earnings Estimates
As of right now, 0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$3.5. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.46 and -$0.46 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.38, with 1 analysts recommending between -$0.38 and -$0.38.
